Related references
Note: Only part of the references are listed.Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy
Barry J. Maron et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of > 10 years
Thomas Kleemann et al.
CIRCULATION (2007)
Receiver-operating characteristic analysis for evaluating diagnostic tests and predictive models
Kelly H. Zou et al.
CIRCULATION (2007)
ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
Douglas P. Zipes et al.
CIRCULATION (2006)
Delayed paced ventricular activation in the long QT syndrome is associated with ventricular fibrillation
Richard C. Saumarez et al.
HEART RHYTHM (2006)
Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy?
KA Ellenbogen et al.
CIRCULATION (2006)
Electrophysiological characteristics of septal hypertrophy in patients with hypertrophic obstructive cardiomyopathy and moderate to severe symptoms
B Schumacher et al.
CIRCULATION (2005)
Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy
AS Adabag et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Numerical simulation of paced electrogram fractionation: Relating clinical observations to changes in fibrosis and action potential duration
I Turner et al.
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY (2005)
What causes sudden death in heart failure?
GF Tomaselli et al.
CIRCULATION RESEARCH (2004)
American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy - A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Gcuidelines
RA Vogel et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2003)
Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: An independent marker of sudden death risk in young patients
L Monserrat et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2003)
Sudden death in noncoronary heart disease is associated with delayed paced ventricular activation
RC Saumarez et al.
CIRCULATION (2003)
Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy
MS Maron et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Hypertrophic cardiomyopathy - A systematic review
BJ Maron
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Activation delay after premature stimulation in chronically diseased human myocardium relates to the architecture of interstitial fibrosis
T Kawara et al.
CIRCULATION (2001)
Relation between myocyte disarray and outcome in hypertrophic cardiomyopathy
AM Varnava et al.
AMERICAN JOURNAL OF CARDIOLOGY (2001)
Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy
PM Elliott et al.
LANCET (2001)
Sudden death in hypertrophic cardiomyopathy: Identification of high risk patients
PM Elliott et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2000)
Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy.
P Spirito et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
